My point is that the COMPANY needs to do a better job publicizing the single-blastomere technology. Believe me, I'm not the only shareholder who thinks this...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.